Identification of risk factors predicting febrile neutropenia in patients with metastatic germ cell tumors receiving cisplatin-based combination chemotherapy
Author:
Affiliation:
1. Department of Urology; Seirei Mikatabara Hospital; Hamamatsu Japan
2. Division of Urology; Kobe University Graduate School of Medicine; Kobe Japan
3. Department of Urology; Hamamatsu University School of Medicine; Hamamatsu Japan
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/iju.13352/fullpdf
Reference21 articles.
1. International patterns and trends in testis cancer incidence;Purdue;Int. J. Cancer,2005
2. Recent strategy for the management of advanced testicular cancer;Nakamura;Int. J. Urol.,2010
3. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I;Krege;Eur. Urol.,2008
4. Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: a systematic review;Lyman;Crit. Rev. Oncol. Hematol.,2014
5. Management of febrile neutropenia: ESMO Clinical Practice Guidelines;Naurois;Ann. Oncol.,2010
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Predictors of the development of febrile neutropenia in chemotherapy for advanced germ cell tumors;International Journal of Urology;2023-11
2. Development and Evaluation of Biotin Functionalized Fullerenes for the Delivery of Irinotecan to Colon Tumors;Current Drug Delivery;2023-08
3. Poor Renal Function and a High Modified Glasgow Prognostic Score Are Predictive Factors for Nedaplatin/5-Fluorouracil Combination Therapy-induced Febrile Neutropenia;Anticancer Research;2023-04-25
4. Synthesis and Antitumor Evaluation of Glutathione Responsive Self-Immolative Disulphide Linked Camptothecin-Biotin Conjugate;Anti-Cancer Agents in Medicinal Chemistry;2022-09-14
5. Effects of primary granulocyte‑colony stimulating factor prophylaxis on the incidence of febrile neutropenia in patients with germ cell tumors;Oncology Letters;2022-07-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3